Add the specialty areas of your choice to tailor excemed.org to your professional interests.
Save & Create free account
No thanks, just apply selection
I already have an account. Login

User login

We offer our registered users tailored information, free online courses and exclusive content.

Can't find your password?
Reset it here.

Scientific Highlights: Growth hormone therapies: Safety and adherence

Scientific Highlights: Growth hormone therapies: Safety and adherence
  • Endocrinology and metabolism
  • Growth disorder

Resource type

Publication

Tags

growth hormone therapy

Many patients require growth hormone for extended periods of time, and, as with any long-term treatment, there have been concerns regarding safety. Surveillance studies are revealing the safety profile of growth hormone therapy in many pathologies, such as isolated growth hormone deficiency, idiopathic short stature and children born small for gestational age, in whom no increased risk of malignancies or neoplasms has been demonstrated. A safety profile for glucose homeostasis was also demonstrated in patients with Turner syndrome. The increased risk for other pathologies in patients previously treated for primary malignancies is, as yet, an unresolved question.

Terms of use

This is a copyrighted resource for the sole purpose of education. Resource may be used for classroom training only and must remain as is, including the branding and EXCEMED logo. It is backed by a publishing license, signed by the author.

Regional workshop
Rio de Janeiro, Brazil
May 30, 2017
Target audience
Latin American paediatric endocrinologists, scientists and all healthcare professionals involved in managing children with growth hormone disorders.
EACCME®
by Excemed
Endocrinology and metabolism